BioMarin Pharmaceutical
BMRN
#1909
Rank
โ‚น924.33 B
Marketcap
โ‚น4,811
Share price
0.60%
Change (1 day)
-14.41%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2025 (TTM): โ‚น58.09 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are โ‚น3.09 Billion. In 2024 the company made an earning of โ‚น48.89 Billion, an increase over its 2023 earnings that were of โ‚น17.01 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น58.09 B18.81%
2024 โ‚น48.89 B187.31%
2023 โ‚น17.01 B26.07%
2022 โ‚น13.49 B-298.51%
2021 -โ‚น6.81 Billion78.04%
2020 -โ‚น3.82 Billion-55.36%
2019 -โ‚น8.56 Billion-33.56%
2018 -โ‚น12.88 Billion297.78%
2017 -โ‚น3.24 Billion-95.68%
2016 -โ‚น75.01 Billion437.12%
2015 -โ‚น13.97 Billion23.91%
2014 -โ‚น11.27 Billion-29.25%
2013 -โ‚น15.93 Billion49.23%
2012 -โ‚น10.68 Billion171.11%
2011 -โ‚น3.94 Billion103.01%
2010 -โ‚น1.94 Billion-3903.54%
2009 โ‚น50.99 M-98.31%
2008 โ‚น3.01 B-189.7%
2007 -โ‚น3.37 Billion51.02%
2006 -โ‚น2.23 Billion-61.58%
2005 -โ‚น5.8 Billion-56.59%
2004 -โ‚น13.35 Billion95.13%
2003 -โ‚น6.85 Billion12.09%
2002 -โ‚น6.11 Billion73.19%
2001 -โ‚น3.53 Billion18.32%
2000 -โ‚น2.98 Billion19.65%
1999 -โ‚น2.49 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ultragenyx Pharmaceutical
RARE
-โ‚น46.82 Billion-176.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-โ‚น9.84 Billion-116.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚น2.48 Billion-104.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น821.32 B 1,239.71%๐Ÿ‡ซ๐Ÿ‡ท France
Amicus Therapeutics
FOLD
โ‚น0.44 B-99.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
โ‚น25.79 B-57.93%๐Ÿ‡บ๐Ÿ‡ธ USA